Skip to: Curated Story Group 1
lifesciencesreview

Advertise

with us

    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Topics
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Business Services
    Business Services
    Business Services
    Business Services
    Business Services
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Pharmacy Management
    Regulatory Services
  • CXO Insights
  • Vendor Viewpoint
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • CXO Awards
AUGUST 2024LIFE SCIENCES REVIEW 5CXO INSIGHTSCharge Reconciliation Challenges ­ Professional Charges and Multiple EMRsMat Clerrico, CRCR, CSPPM, CSPR,Revenue Cycle Director,South County Health32The Human Element in Medical Billing and Revenue CycleOlivia Wolf,Director of Business Development Strategy,Southcentral Foundation19Navigating Revenue Cycle Management with Emerging Technologies and Strategic InnovationsMea Ford, MPA, CLSSGB,System Vice President of Revenue Cycle, Renown Health2230The Impact of AI on FP&A in the Life Sciences SectorLina Parra Cartagena,Associate Director of Finance,Vertex PharmaceuticalsThink biology if you want to invest beyond commodity AIAshot Arzumanyan,Partner,SmartGateVC27State of the IndustryFuelling the Future of Biotechnology and Medicine16Importance of Revenue Integrity Programs in HealthcareJames M Lindgren,Associate Vice President -Business and Revenue Cycle Applications,University of Miami24Heather Rose, CEO Julien Roeser, General Manager1826TRANSFORMING HEALTHCARE WITH CUSTOMIZED SOLUTIONSADVANCING RESEARCH, ACCELERATING DISCOVERYP3 TechnologyQuantall
< Page 4 | Page 6 >